patent on semaglutide As the for semaglutide, the key ingredient in the popular weight-loss drug Ozempic, is set to expire in March, Indian pharmaceutical giants are gearing up to flood the market with generic Semaglutide generics flood Indian market
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Semaglutide generics flood Indian market after patent expiry Schenella Lobo posted on the topic LinkedIn Semaglutide: Just Another Off Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the patent protecting Novo Nordisk's semaglutide expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants Novo Nordisk Braces as Generic Weight Loss Drugs Come to Upend Market Bloomberg The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in India on March 20, opening the door for a wave of low cost Off patent semaglutide in 2026: the next revolution in anti obesity medications IQVIA Ozempic's Key Molecule To Go Off Patent: What Changes Now?
Store: armz-ageddon.com · Domain: armz-ageddon.com


)
















